Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 3 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Lymphoid 1Classical hematology 1

Conditions

Multiple Myeloma 338Neoplasms, Plasma Cell 62Recurrence 39Lymphoma, Non-Hodgkin 37Leukemia, Lymphocytic, Chronic, B-Cell 35Lymphoma 31Hodgkin Disease 31Precursor Cell Lymphoblastic Leukemia-Lymphoma 27Lymphoma, Mantle-Cell 27Lymphoma, Large B-Cell, Diffuse 27Immunoglobulin Light-chain Amyloidosis 27Lymphoma, Follicular 26Lymphoma, Large-Cell, Immunoblastic 25Lymphoma, B-Cell, Marginal Zone 25Leukemia, Myeloid, Acute 25Neoplasms 24Burkitt Lymphoma 23Leukemia, Myeloid, Chronic-Phase 22Myeloproliferative Disorders 21Leukemia, Myeloid, Accelerated Phase 21Leukemia 21Blast Crisis 21Primary Myelofibrosis 20Lymphoma, T-Cell, Cutaneous 20Leukemia, Hairy Cell 19Waldenstrom Macroglobulinemia 16Myelodysplastic Syndromes 16Leukemia, Myelomonocytic, Chronic 16Sezary Syndrome 15Mycosis Fungoides 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Blood Coagulation Disorders × Plasma cell × Clear all
NCT06963216 2026-05-11

A Study Investigating Coagadex in the Treatment AFXD Associated With AL Amyloidosis

Kedrion S.p.A.

Phase 3 Recruiting
15 enrolled
Plasma cell

Immunoglobulin Light-chain Amyloidosis, Blood Coagulation Disorders, Factor X Deficiency, Hematologic Diseases, Hemorrhagic Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡